RxDoctor Payments Data

Jaynah Mistry, PA

Physician Assistant · Silver Spring, MDNPI 1568915015

Payments from drug & device makers

$8,361in general payments, 2019–2025

Across 360 payments — averaging $23.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • Novartis$865
  • Merck$700
  • Incyte Corporation$372
  • Daiichi Sankyo Inc.$309
  • AstraZeneca$256
  • plus $5K from 54 others

What the payments were for

  • Food & beverage$8,26199%
  • Education$1001%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson(2 entities)42$1,085
Novartis40$865
Merck36$700
Incyte Corporation15$372
Daiichi Sankyo Inc.12$309
AstraZeneca(2 entities)11$256
Takeda Pharmaceuticals U.S.A., Inc.12$249
AbbVie11$232
Bayer9$216
Lilly USA, LLC10$208
Regeneron Healthcare Solutions, Inc.9$204
Genentech USA, Inc.9$201
Seagen Inc.8$181
Eisai Inc.8$180
Pharmaessentia USA Corporation7$180
Ipsen Biopharmaceuticals, Inc8$177
Sanofi7$160
Tersera Therapeutics LLC5$150
Taiho Oncology, Inc.5$133
Amgen8$133
Novo Nordisk1$125
Pfizer6$124
ADC Therapeutics America, Inc.5$123
Exelixis Inc.5$117
Kyowa Kirin, Inc.5$110
Puma Biotechnology, Inc.6$104
GSK3$104
Mirati Therapeutics, Inc.3$101
Davol Inc.1$93
Karyopharm Therapeutics Inc.3$82
Beone Medicines USA, Inc.3$75
Genmab U.S., Inc.2$69
G1 Therapeutics, Inc.3$67
Sobi, Inc3$66
Array Biopharma Inc3$63
Blueprint Medicines Corporation2$51
Pharmacosmos Therapeutics Inc.2$49
Rigel Pharmaceuticals, Inc.2$45
Morphosys, US Inc.2$45
Astellas Pharma US Inc2$42
Deciphera Pharmaceuticals Inc.3$42
Alnylam Pharmaceuticals Inc.3$41
Heron Therapeutics, Inc.1$32
Mylan Specialty L.p.1$31
Boehringer Ingelheim1$29
EMD Serono, Inc.1$26
Fennec Pharmaceuticals, Inc.1$25
Tolmar Pharmaceuticals, Inc.1$25
Fresenius Kabi USA, LLC1$24
Invivyd Inc1$24
Janssen Scientific Affairs, LLC1$23
Agios Pharmaceuticals, Inc.1$23
Syndax Pharmaceuticals, Inc.1$23
Spectrum Pharmaceuticals Inc.1$22
Beigene USA, Inc.1$19
Smith+Nephew1$18
Adaptive Biotechnologies Corporation1$17
Recordati_rare_diseases_inc.1$16
Sanofi-aventis U.S. LLC1$16
Servier Pharmaceuticals LLC1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,361 in reported general payments places this provider in the 95th percentile of 2,567 physician assistant providers in Maryland.

See all physician assistant providers in Maryland

Medicare billing

Part B allowed, 2024
$115,668
Medicare patients
471
Services billed
1,194

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other physician assistant in Silver Spring

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →